Sleep Arousal-Related Ventricular Repolarization Lability Is Associated With Cardiovascular Mortality in Older Community-Dwelling Men

Sobhan Salari Shahrbabaki, Dominik Linz, Susan Redline, Katie Stone, Kristine Ensrud, Mathias Baumert, Sobhan Salari Shahrbabaki, Dominik Linz, Susan Redline, Katie Stone, Kristine Ensrud, Mathias Baumert

Abstract

Background: Sleep is fragmented by brief arousals, and excessive arousal burden has been linked to increased cardiovascular (CV) risk, but mechanisms are poorly understood.

Research question: Do arousals trigger cardiac ventricular repolarization lability that may predispose people to long-term cardiovascular mortality?

Study design and methods: This study analyzed 407,541 arousals in the overnight polysomnograms of 2,558 older men in the Osteoporotic Fractures in Men sleep study. QT and RR intervals were measured beat-to-beat starting 15 s prior to arousal onset until 15 s past onset. Ventricular repolarization lability was quantified by using the QT variability index (QTVi).

Results: During 10.1 ± 2.5 years of follow-up, 1,000 men died of any cause, including 348 CV deaths. During arousals, QT and RR variability increased on average by 5 and 55 ms, respectively, resulting in a paradoxical transient decrease in QTVi from 0.07 ± 1.68 to -1.00 ± 1.68. Multivariable Cox proportional hazards analysis adjusted for age, BMI, cardiovascular and respiratory risk factors, sleep-disordered breathing and arousal, diabetes, and Parkinson disease indicated that excessive QTVi during arousal was independently associated with all-cause and CV mortality (all-cause hazard ratio, 1.20 [95% CI, 1.04-1.38; P = .012]; CV hazard ratio, 1.29 [95% CI, 1.01 -1.65; P = .043]).

Interpretation: Arousals affect ventricular repolarization. A disproportionate increase in QT variability during arousal is associated with an increased all-cause and CV mortality and may reflect ventricular repolarization maladaptation to the arousal stimulus. Whether arousal-related QTVi can be used for more tailored risk stratification warrants further study, including evaluating whether arousal suppression attenuates ventricular repolarization lability and reduces subsequent mortality.

Clinical trial registration: ClinicalTrials.gov; No.: NCT00070681; URL: www.

Clinicaltrials: gov.

Keywords: QT variability index; all-cause mortality; cardiovascular mortality; sleep apnea; sleep arousal; ventricular repolarization.

Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.

Figures

Figure 1
Figure 1
A, Graphical example of ECG and EEG activation during an arousal episode. Heart period and repolarization variability prior to (B), during (C), and following (D) the onset of arousal from sleep. P value indicates the repeated measures analysis of variance results. SDQT and SDRR = QT and RR variance; QTVi = QT variability index.
Figure 2
Figure 2
QTVi and mortality. All-cause mortality across QTVi quartiles at baseline (A), arousal onset (C), and postarousal onset (E). Cumulative incident function curves comparing the competing risk of CV and non-CV mortality of dichotomized QTVi at baseline (B), arousal onset (D), and postarousal onset (F). QTVi values were dichotomized using the fourth quartile of the arousal onset QTVi distribution. P value shows log-rank test results. CV = cardiovascular; Q1-Q4 = quartiles of the QT variability index for Baseline QTVi, Arousal onset QTVi and Post Arousal onset QTVi; QTVi = QT variability index.
Figure 3
Figure 3
The exposure-response relationship of arousal-related QTVi and CV mortality adjusted for age, history of stroke, myocardial infarction/coronary artery disease, atrial fibrillation, congestive heart failure, diabetes, hypertension, COPD, asthma, mean heart rate, mean respiratory rate, Physical Activity Scale for Elderly, systolic and diastolic blood pressures, time of sleep spent below 90% oxygen saturation, BMI, apnea-hypopnea index, arousal index, average corrected QT, arousal burden, and drink and smoking habit. CV = cardiovascular; QTVi = QT variability index.
Figure 4
Figure 4
Cumulative incident function curves compare the competing risk of cardiovascular and noncardiovascular mortality in the men of the first quartile of baseline QTVi. Group 1 represents men whose QTVi values following arousal onset were still in Q1 (QTVi less than –0.96); Group 2 represents participants whose QTVi shifted to upper quartiles (Q2-Q4) following arousal onset. The P value indicates log-rank test results. HR = hazard ratio; QTVi = QT variability index.

References

    1. Iber C., Ancoli-Israel A., Chesson A., Quan S.F. American Academy of Sleep Medicine; 2007. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications.
    1. Shahrbabaki S.S., Linz D., Hartmann S., Redline S., Baumert M. Sleep arousal burden is associated with long-term all-cause and cardiovascular mortality in 8001 community-dwelling older men and women. Eur Heart J. 2021;21:2088–2099.
    1. Cowie M.R., Linz D., Redline S., Somers V.K., Simonds A.K. Sleep disordered breathing and cardiovascular disease: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021;78(6):608–624.
    1. Floras J.S. Sympathetic nervous system in patients with sleep related breathing disorders. Cur Hypertension Rev. 2016;12(1):18–26.
    1. Linz D., Baumert M., Catcheside P., et al. Assessment and interpretation of sleep disordered breathing severity in cardiology: clinical implications and perspectives. Int J Cardiol. 2018;271:281–288.
    1. Oosterhoff P., Tereshchenko L.G., van der Heyden M.A., et al. Short-term variability of repolarisation predicts ventricular tachycardia and sudden cardiac death in patients with structural heart disease: a comparison with QT variability index. Heart Rhythm. 2011;8(10):1584–1590.
    1. Piccirillo G., Magrì D., Matera S., et al. QT variability strongly predicts sudden cardiac death in asymptomatic subjects with mild or moderate left ventricular systolic dysfunction: a prospective study. Eur Heart J. 2007;28(11):1344–1350.
    1. Karisik F., Baumert M. Template adaptation of 2D quasi-periodic data using a soft-assign localized correspondence matrix. IEEE T Signal Process. 2021;69:826–836.
    1. Schmidt M., Baumert M., Malberg H., Zaunseder S. Iterative two-dimensional signal warping—towards a generalized approach for adaption of one-dimensional signals. Biomed Signal Process Control. 2018;43:311–319.
    1. Orwoll E., Blank J.B., Barrett-Connor E., et al. Design and baseline characteristics of the Osteoporotic Fractures in Men (MrOS) study—a large observational study of the determinants of fracture in older men. Contemp Clin Trials. 2005;26(5):569–585.
    1. Blank J.B., Cawthon P.M., Carrion-Petersen M.L., et al. Overview of recruitment for the Osteoporotic Fractures in Men study (MrOS) Contemp Clin Trials. 2005;26(5):557–568.
    1. NCT. Identifier: NCT00070681.
    1. Mehra R., Stone K.L., Blackwell T., et al. Osteoporotic Fractures in Men Study. Prevalence and correlates of sleep-disordered breathing in older men: osteoporotic fractures in men sleep study. J Am Geriatr Soc. 2007;55(9):1356–1364.
    1. Baumert M., Linz D., Stone K., et al. Mean nocturnal respiratory rate predicts cardiovascular and all-cause mortality in community-dwelling older men and women. Eur Respir J. 2019;54(1)
    1. Koo B.B., Blackwell T., Ancoli-Israel S., Stone K.L., Stefanick M.L., Redline S. Association of incident cardiovascular disease with periodic limb movements during sleep in older men. Circulation. 2011;124(11):1223–1231.
    1. May A.M., May R.D., Bena J., et al. Osteoporotic Fractures in Men (MrOS) Study Group. Individual periodic limb movements with arousal are temporally associated with nonsustained ventricular tachycardia: a case-crossover analysis. Sleep. 2019;42(11):zsz165.
    1. Schmidt M., Baumert M., Porta A., Malberg H., Zaunseder S. Two-dimensional warping for one-dimensional signals—conceptual framework and application to ECG processing. IEEE T Signal Process. 2014;62(21):5577–5588.
    1. Hasan M.A., Abbott D., Baumert M. Relation between beat-to-beat QT interval variability and T-wave amplitude in healthy subjects. Ann Noninvasive Electrocardiol. 2012;17(3):195–203.
    1. Baumert M., Immanuel S.A., Stone K.L., et al. Composition of nocturnal hypoxaemic burden and its prognostic value for cardiovascular mortality in older community-dwelling man. Eur Heart J. 2020;41:533–541.
    1. Baumert M., Smith J., Catcheside P., et al. Variability of QT interval duration in obstructive sleep apnea: an indicator of disease severity. Sleep. 2008;31(7):959–966.
    1. Rossi V.A., Stoewhas A.C., Camen G., et al. The effects of continuous positive airway pressure therapy withdrawal on cardiac repolarisation: data from a randomized controlled trial. Eur Heart J. 2012;33:2206–2212.
    1. Ryan C.M., Usui K., Floras J.S., Bradley T.D. Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. Thorax. 2005;60:781–785.
    1. Schmidt M., Baumert M., Penzel T., Malberg H., Zaunseder S. Nocturnal ventricular repolarisation lability predicts cardiovascular mortality in the Sleep Heart Health Study. Am J Physiol Heart Circ Physiol. 2019;316(3):H495–H505.
    1. Baumert M., Porta A., Vos M.A., et al. QT interval variability in body surface ECG: measurement, physiological basis, and clinical value: position statement and consensus guidance endorsed by the European Heart Rhythm Association jointly with the ESC Working Group on Cardiac Cellular Electrophysiology. Europace. 2016;18(6):925–944.
    1. Linz B., Sattler S.M., Flethøj M., et al. Arrhythmogenic mechanisms of acute obstructive respiratory events in a porcine model of drug-induced long QT. Heart Rhythm. 2021;18(8):1384–1391.
    1. Wang N., Sun Y., Zhang H., et al. Long-term night shift work is associated with the risk of atrial fibrillation and coronary heart disease. Eur Heart J. 2021;42(40):4180–4188.
    1. Kröller-Schön S., Daiber A., Steven S., et al. Crucial role for Nox2 and sleep deprivation in aircraft noise-induced vascular and cerebral oxidative stress, inflammation, and gene regulation. Eur Heart J. 2018;39(38):3528–3539.
    1. Wang C., Bangdiwala S.I., Rangarajan S., et al. Association of estimated sleep duration and naps with mortality and cardiovascular events: a study of 116,632 people from 21 countries. Eur Heart J. 2019;40(20):1620–1629.
    1. Reinhard W., Plappert N., Zeman F., et al. Prognostic impact of sleep duration and sleep efficiency on mortality in patients with chronic heart failure. Sleep Med. 2013;14(6):502–509.
    1. Spiesshoefer J., Linz D., Skobel E., et al. on behalf of the German Cardiac Society Working Group on Sleep Disordered Breathing Ag-Deutsche Gesellschaft Für Kardiologie Herz Und Kreislaufforschung E V Sleep—the yet underappreciated player in cardiovascular diseases: a clinical review from the German Cardiac Society Working Group on Sleep Disordered Breathing. Eur J Prev Cardiol. 2019;28(2):189–200.
    1. Somers V.K., Dyken M.E., Mark A.L., Abboud F.M. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med. 1993;328(5):303–307.
    1. Baumert M., Schlaich M.P., Nalivaiko E., et al. Relation between QT interval variability and cardiac sympathetic activity in hypertension. Am J Physiol Heart Circ Physiol. 2011;300(4):H1412–H1417.
    1. Rizas K.D., Nieminen T., Barthel P., et al. Sympathetic activity-associated periodic repolarization dynamics predict mortality following myocardial infarction. J Clin Invest. 2014;124(4):1770–1780.
    1. Sampedro-Puente D.A., Fernandez-Bes J., Porter B., van Duijvenboden S., Taggart P., Pueyo E. Mechanisms underlying interactions between low-frequency oscillations and beat-to-beat variability of cellular ventricular repolarization in response to sympathetic stimulation: implications for arrhythmogenesis. Front Physiol. 2019;10:916.
    1. Baker-Smith C.M., Isaiah A., Melendres M.C., et al. American Heart Association Athero, Hypertension and Obesity in the Young Committee of the Council on Lifelong Congenital Heart Disease and Heart Health in the Young. Sleep-disordered breathing and cardiovascular disease in children and adolescents: a scientific statement from the American Heart Association. J Am Heart Assoc. 2021
    1. Azarbarzin A., Sands S.A., Stone K.L., et al. The hypoxic burden of sleep apnoea predicts cardiovascular disease-related mortality: the Osteoporotic Fractures in Men Study and the Sleep Heart Health Study. Eur Heart J. 2019;40(14):1149–1157.
    1. Linz D., Loffler K.A., Sanders P., et al. Low prognostic value of novel nocturnal metrics in patients with OSA and high cardiovascular event risk: post hoc analyses of the SAVE Study. Chest. 2020;158(6):2621–2631.
    1. Azarbarzin A., Sands S.A., Younes M., et al. The sleep apnea-specific pulse-rate response predicts cardiovascular morbidity and mortality. Am J Respir Crit Care Med. 2021;203(12):1546–1555.33.
    1. Yaghini Bonabi S., El-Hamad F., Müller A., et al. Recording duration and short-term reproducibility of heart rate and QT interval variability in patients with myocardial infarction. Physiol Meas. 2016;37(11):1925–1933.
    1. Giudicessi J.R., Schram M., Bos J.M., et al. Artificial intelligence-enabled assessment of the heart rate corrected QT interval using a mobile electrocardiogram device. Circulation. 2021;143(13):1274–1286.
    1. Rizas K.D., Doller A.J., Hamm W., et al. Periodic repolarization dynamics as a risk predictor after myocardial infarction: prospective validation study. Heart Rhythm. 2019;16(8):1223–1231.
    1. Bauer A., Klemm M., Rizas K.D., et al. Prediction of mortality benefit based on periodic repolarisation dynamics in patients undergoing prophylactic implantation of a defibrillator: a prospective, controlled, multicentre cohort study. Lancet. 2019;394(10206):1344–1351.

Source: PubMed

3
Subskrybuj